Clinical drug research in chronic central neurodegenerative disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical drug research in chronic central neurodegenerative disorders
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 16, Issue 5, Pages 497-504
Publisher
Informa UK Limited
Online
2016-03-08
DOI
10.1586/14737175.2016.1163220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products
- (2016) Manika Awasthi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Tau immunization: a cautionary tale?
- (2015) Alexandra J. Mably et al. NEUROBIOLOGY OF AGING
- Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice
- (2015) Alexandra J. Mably et al. NEUROBIOLOGY OF DISEASE
- Connecting the dots between tau dysfunction and neurodegeneration
- (2015) Bess Frost et al. TRENDS IN CELL BIOLOGY
- Alzheimer's disease progression model based on integrated biomarkers and clinical measures
- (2014) Yue Qiu et al. ACTA PHARMACOLOGICA SINICA
- Expanding efforts to address Alzheimer's disease: The Healthy Brain Initiative
- (2014) Lynda A. Anderson et al. Alzheimers & Dementia
- Effects of Tai Chi on balance and fall prevention in Parkinson’s disease: a randomized controlled trial
- (2014) Qiang Gao et al. CLINICAL REHABILITATION
- The physiology and pathology of microtubule-associated protein tau
- (2014) Jian-Zhi Wang et al. Essays in Biochemistry
- Amyloid-β Pathology andAPOEGenotype Modulate Retinoid X Receptor Agonist Activityin Vivo
- (2014) Leon M. Tai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease
- (2014) C Liguori et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Photoreceptor layer thinning in idiopathic Parkinson's disease
- (2014) Nicolas M. Roth et al. MOVEMENT DISORDERS
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
- (2014) Lars Lannfelt et al. Alzheimers Research & Therapy
- The potential applications of Apolipoprotein E in personalized medicine
- (2014) Sylvia Villeneuve et al. Frontiers in Aging Neuroscience
- Deep Brain Stimulation Induces Striatal Dopamine Release in Obsessive-Compulsive Disorder
- (2013) Martijn Figee et al. BIOLOGICAL PSYCHIATRY
- Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
- (2013) Yun Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson’s disease
- (2013) Thomas Müller Expert Review of Neurotherapeutics
- Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
- (2013) Fabio Blandini Journal of Neuroimmune Pharmacology
- Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study
- (2013) Roberto Ceravolo et al. MOVEMENT DISORDERS
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery
- (2013) Thomas Müller et al. PARKINSONISM & RELATED DISORDERS
- Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs
- (2013) Constanze Jugel et al. PLoS One
- Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial
- (2013) M. van Nimwegen et al. BMJ-British Medical Journal
- Disease Modifying Therapies for Alzheimer's Disease Targeting AβOligomers: Implications for Therapeutic Mechanisms
- (2013) Etsuro Matsubara et al. Biomed Research International
- Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease
- (2012) Erin R. Foster et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Amantadine: The journey from fighting flu to treating Parkinson disease
- (2012) G. Hubsher et al. NEUROLOGY
- Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
- (2011) Carl E. Clarke et al. MOVEMENT DISORDERS
- Effect of exercise on reactivity and motor behaviour in patients with Parkinson's disease
- (2010) T. Muller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mechanisms compensating for dopamine loss in early Parkinson disease
- (2009) J. Brotchie et al. NEUROLOGY
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started